Article metrics

other Versions

Download PDFPDF

A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician’s choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)

 

Online download statistics by month:

Online download statistics by month: June 2020 to January 2021

AbstractFullPdf
Jun 202013112344
Jul 202019819054
Aug 202036235461
Sep 202018418227
Oct 202012212213
Nov 2020868522
Dec 2020635818
Jan 2021635918
Total12091173257